Correlation Between Achilles Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Achilles Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Achilles Therapeutics and Neurobo Pharmaceuticals
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Achilles and Neurobo is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Achilles Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.39 times more return on investment than Neurobo Pharmaceuticals. However, Achilles Therapeutics PLC is 2.58 times less risky than Neurobo Pharmaceuticals. It trades about 0.23 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 99.00 in Achilles Therapeutics PLC on August 28, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Achilles Therapeutics PLC vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Achilles Therapeutics PLC |
| Neurobo Pharmaceuticals |
Achilles Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Achilles Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Achilles Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |